Key result
HFpEF was associated with lower mortality compared with HFrEF in acute decompensated heart failure (40.0% vs 44.7%; P=0.007), but not in de novo acute heart failure (27.7% vs 26.9%; P=0.14).
Population
5,414 patients with acute heart failure with available ejection fraction data, including 2,867 with de novo…
Design
Cohort
Authors
Loading...
Outcomes in acute HF by EF category remain unclear; leaves open whether HFmrEF prognosis differs enough to guide distinct care.
Cohort (n=5,414)
Yes
Hazard Ratio: 1.15 (95% CI 0.96–1.38)
Absolute Event Rate: 27.7% vs 26.9%
p-value: p=0.14
The prognostic impact of ejection fraction in acute heart failure differs based on whether the presentation is de novo or an acute decompensation of chronic heart failure.
Choi et al. (2017) conducted a cohort in De novo acute heart failure or acute decompensated heart failure (n=5,414). Heart failure with preserved ejection fraction (HFpEF) vs. Heart failure with reduced ejection fraction (HFrEF) was evaluated on All-cause death (in de novo acute heart failure) (adjusted HR 1.15, 95% CI 0.96 to 1.38, p=0.14). HFpEF was associated with lower mortality compared with HFrEF in acute decompensated heart failure (40.0% vs 44.7%; P=0.007), but not in de novo acute heart failure (27.7% vs 26.9%; P=0.14).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: